Ann F. Chambers

28.9k total citations · 3 hit papers
285 papers, 23.1k citations indexed

About

Ann F. Chambers is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Ann F. Chambers has authored 285 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 118 papers in Oncology and 88 papers in Rheumatology. Recurrent topics in Ann F. Chambers's work include Bone and Dental Protein Studies (85 papers), Cancer Cells and Metastasis (60 papers) and dental development and anomalies (36 papers). Ann F. Chambers is often cited by papers focused on Bone and Dental Protein Studies (85 papers), Cancer Cells and Metastasis (60 papers) and dental development and anomalies (36 papers). Ann F. Chambers collaborates with scholars based in Canada, United States and United Kingdom. Ann F. Chambers's co-authors include Ian C. MacDonald, A. C. Groom, Alan B. Tuck, L M Matrisian, Sylvia M. Wilson, Eric E. Schmidt, Vincent L. Morris, Nancy Kerkvliet, Najla Guthrie and John F. Harris and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ann F. Chambers

283 papers receiving 22.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dissemination and growth of cancer cells in metastatic sites

2002 3.0k citations Ann F. Chambers, A. C. Groom et al. profile →
Changing views of the role of matrix metalloproteinases in metastasis

1997 1.3k citations Ann F. Chambers et al. profile →
Multistep Nature of Metastatic Inefficiency

1998 953 citations Ian C. MacDonald, Nancy Kerkvliet et al. American Journal Of Pathology profile →

Peers

Countries citing papers authored by Ann F. Chambers

Since Specialization

Citations

This map shows the geographic impact of Ann F. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann F. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann F. Chambers more than expected).

Fields of papers citing papers by Ann F. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann F. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann F. Chambers. The network helps show where Ann F. Chambers may publish in the future.

Co-authorship network of co-authors of Ann F. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Ann F. Chambers. A scholar is included among the top collaborators of Ann F. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann F. Chambers. Ann F. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Muriel Brackstone, David A. Palma, Alan B. Tuck, Leslie A. Scott, Kylea Potvin, Theodore A. Vandenberg, Francisco Perera, David D’Souza, Donald H. Taves, Anat Kornecki, (unknown), Ann F. Chambers	43
2	Quantification of cancer cell extravasation in vivo 2016 ·Nature Protocols ·Yohan Kim, Karla C. Williams, (unknown), (unknown), Ann F. Chambers, Hon S. Leong	57
3	Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer 2011 ·Molecular Cancer Research ·Patricia M. McGowan, (unknown), Emeline J. Ribot, Paula J. Foster, Diane Palmieri, Patricia S. Steeg, Alison L. Allan, Ann F. Chambers	116
4	Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis 2011 ·Laboratory Investigation ·Brigitte Goulet, (unknown), Amber Ablack, Carl O. Postenka, M. Nicole Hague, Joe S. Mymryk, Alan B. Tuck, Vincent Giguère, Ann F. Chambers, John D. Lewis	49
5	Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line 2011 ·International Journal of Cancer ·Philip J. Medeiros, Baraa K. Al‐Khazraji, Nicole Novielli, Lynne‐Marie Postovit, Ann F. Chambers, Dwayne N. Jackson	54
6	Role of the metastasis‐promoting protein osteopontin in the tumour microenvironment 2010 ·Journal of Cellular and Molecular Medicine ·Pieter H. Anborgh, (unknown), Alan B. Tuck, Ann F. Chambers	163
7	Three-Dimensional Imaging and Quantification of Both Solitary Cells and Metastases in Whole Mouse Liver by Magnetic Resonance Imaging 2009 ·Cancer Research ·Jason L. Townson, Soha S. Ramadan, (unknown), Brian K. Rutt, Ian C. MacDonald, Paula J. Foster, Ann F. Chambers	28
8	Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton 2008 ·Cancer Research ·Dalit Barkan, Hynda K. Kleinman, Justin L. Simmons, Holly Asmussen, Anil K. Kamaraju, Mark J. Hoenorhoff, Zi-yao Liu, Sylvain V. Costes, Edward H. Cho, Stephen Lockett, Chand Khanna, Ann F. Chambers, Jeffrey E. Green	325
9	Osteopontin Expression in Normal Skin and Non-melanoma Skin Tumors 2007 ·Journal of Histochemistry & Cytochemistry ·Pi‐Ling Chang, (unknown), (unknown), Patricia H. Hicks, Kraisorn Sappayatosok, (unknown), Somporn Swasdison, Ann F. Chambers, Craig A. Elmets, Kang-Jey Ho	37
10	Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer 2006 ·American Journal Of Pathology ·Alison L. Allan, (unknown), Sharon A. Vantyghem, Mark W. Lee, Nicole C. Hodgson, C. Jay Engel, R. L. Holliday, David Girvan, Leslie A. Scott, Carl O. Postenka, Waleed Al‐Katib, Larry Stitt, Toshimitsu Uede, Ann F. Chambers, Alan B. Tuck	86
11	Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways 2003 ·Oncogene ·Alan B. Tuck, Charulata Hota, Sylvia M. Wilson, Ann F. Chambers	115
12	The vascular-targeting agent, ZD6126, and the antiangiogenic agent, ZD6474, inhibit liver metastases via differential effects on metastatic vasculature. 2003 ·Clinical Cancer Research ·Hemanth J. Varghese, Lisa T. MacKenzie, A. C. Groom, Christopher G. Ellis, Anderson J. Ryan, Ian C. MacDonald, Ann F. Chambers	1
13	Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin. 2003 ·PubMed ·(unknown), Alison L. Allan, Sylvia M. Wilson, Charulata Hota, Sharon A. Vantyghem, Carl O. Postenka, Waleed Al‐Katib, Ann F. Chambers, Alan B. Tuck	79
14	Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis 2003 ·The Journal of Immunology ·Daria Leali, Patrizia Dell’Era, Helena Stabile, Barbara Sennino, Ann F. Chambers, Antonella Naldini, Silvano Sozzani, Beatrice Nico, Doménico Ribatti, Marco Presta	104
15	Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. 2002 ·PubMed ·Hemanth J. Varghese, Melanie Davidson, Ian C. MacDonald, Sylvia M. Wilson, (unknown), A. C. Groom, Ann F. Chambers	50
16	Transurethral Resection Syndrome—It Does Not Have to be a Mystery 2002 ·AORN Journal ·Ann F. Chambers	7
17	Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. 2000 ·PubMed ·Catherine L. Nutt, Mark Noble, Ann F. Chambers, J. Gregory Cairncross	81
18	The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer 1996 ·Human Pathology ·Frances P. O’Malley, Zahida Saad, Nancy Kerkvliet, Gordon S. Doig, Larry Stitt, Peter Ainsworth, (unknown), Ann F. Chambers, (unknown), Vivien Bramwell	48
19	Identification of a ras -Activated Enhancer in the Mouse Osteopontin Promoter and Its Interaction with a Putative ETS-Related Transcription Factor Whose Activity Correlates with the Metastatic Potential of the Cell 1995 ·Molecular and Cellular Biology ·(unknown), (unknown), Duane A. Mitchell, David T. Denhardt, Ann F. Chambers	73
20	Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue. 1995 ·PubMed ·Jim W. Xuan, Jonathan Chin, Ying Guo, Ann F. Chambers, (unknown), (unknown)	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact